SCHEMBL11351829

SCHEMBL11351829

O=C(Nc1ccc(C(=O)Nc2ccc3ccc(S(=O)(=O)O)cc3c2O)cc1)Nc1ccc(C(=O)Nc2ccc3ccc(S(=O)(=O)O)cc3c2O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TIMP3 P35625 6/20 0.58
F11 P03951 2/20 0.51
FGF1 P05230 1/20 0.50
PRMT1 Q99873 2/20 0.49
CASP6 P55212 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
MEN1 O00255 4/20 0.46
RECQL P46063 4/20 0.46
KMT2A Q03164 4/20 0.46
HSD17B10 Q99714 4/20 0.46
TDP1 Q9NUW8 4/20 0.46
USP2 O75604 2/20 0.46
ALDH1A1 P00352 1/20 0.46
ENPP2 Q13822 3/20 0.45
APEX1 P27695 3/20 0.44
ELANE P08246 1/20 0.44
CTSG P08311 1/20 0.44
CYP1A2 P05177 3/20 0.43
MAPT P10636 3/20 0.43
PKM P14618 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10909096 0.93 TIMP3 (0.50) TIMP3F11FGF1PRMT1CASP6
SCHEMBL11352189 0.92 TIMP3 (0.57) TIMP3F11FGF1PRMT1CASP6
SCHEMBL11340312 0.87 RECQL (0.62) TIMP3PRMT1MEN1RECQLKMT2A
SCHEMBL11424939 0.86 CASP6 (0.57) TIMP3PRMT1CASP6CTDSP1MEN1
SCHEMBL11341877 0.85 P2RY11 (0.46) TIMP3PRMT1MEN1RECQLKMT2A
SCHEMBL10907420 0.84 CASP6 (0.52) TIMP3F11FGF1PRMT1CASP6
SCHEMBL11347346 0.84 TIMP3 (0.60) TIMP3F11FGF1PRMT1CASP6
SCHEMBL10823591 0.84 PRMT1 (0.50) TIMP3PRMT1MEN1KMT2AMAPT
SCHEMBL11431164 0.83 MAPT (0.56) CASP6MEN1KMT2AALDH1A1MAPT
SCHEMBL11344456 0.83 TIMP3 (0.58) TIMP3F11FGF1PRMT1CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 US disclosed